Annual Net Income:
$4.41B+$459.00M(+11.61%)Summary
- As of today, REGN annual net profit is $4.41 billion, with the most recent change of +$459.00 million (+11.61%) on December 31, 2024.
- During the last 3 years, REGN annual net income has fallen by -$3.66 billion (-45.36%).
- REGN annual net income is now -45.36% below its all-time high of $8.08 billion, reached on December 31, 2021.
Performance
REGN Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
$1.39B+$582.90M(+72.08%)Summary
- As of today, REGN quarterly net profit is $1.39 billion, with the most recent change of +$582.90 million (+72.08%) on June 30, 2025.
- Over the past year, REGN quarterly net income has dropped by -$40.70 million (-2.84%).
- REGN quarterly net income is now -55.09% below its all-time high of $3.10 billion, reached on June 30, 2021.
Performance
REGN Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
$4.46B-$40.70M(-0.90%)Summary
- As of today, REGN TTM net profit is $4.46 billion, with the most recent change of -$40.70 million (-0.90%) on June 30, 2025.
- Over the past year, REGN TTM net income has increased by +$136.90 million (+3.17%).
- REGN TTM net income is now -44.79% below its all-time high of $8.08 billion, reached on December 31, 2021.
Performance
REGN TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
REGN Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +11.6% | -2.8% | +3.2% |
| 3Y3 Years | -45.4% | +63.3% | -21.6% |
| 5Y5 Years | +108.5% | +55.1% | +41.3% |
REGN Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -45.4% | +11.6% | -2.8% | +92.7% | -17.0% | +15.6% |
| 5Y | 5-Year | -45.4% | +108.5% | -55.1% | +92.7% | -44.8% | +41.3% |
| All-Time | All-Time | -45.4% | +2089.8% | -55.1% | +2326.4% | -44.8% | +2110.6% |
REGN Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.39B(+72.1%) | $4.46B(-0.9%) |
| Mar 2025 | - | $808.70M(-11.9%) | $4.50B(+2.0%) |
| Dec 2024 | $4.41B(+11.6%) | $917.70M(-31.5%) | $4.41B(-5.2%) |
| Sep 2024 | - | $1.34B(-6.4%) | $4.65B(+7.7%) |
| Jun 2024 | - | $1.43B(+98.4%) | $4.32B(+12.0%) |
| Mar 2024 | - | $722.00M(-37.7%) | $3.86B(-2.4%) |
| Dec 2023 | $3.95B(-8.9%) | $1.16B(+15.1%) | $3.95B(-0.9%) |
| Sep 2023 | - | $1.01B(+4.1%) | $3.99B(-7.2%) |
| Jun 2023 | - | $968.40M(+18.4%) | $4.30B(+2.8%) |
| Mar 2023 | - | $817.80M(-31.7%) | $4.18B(-3.6%) |
| Dec 2022 | $4.34B(-46.3%) | $1.20B(-9.0%) | $4.34B(-19.2%) |
| Sep 2022 | - | $1.32B(+54.4%) | $5.37B(-5.6%) |
| Jun 2022 | - | $852.10M(-12.5%) | $5.69B(-28.3%) |
| Mar 2022 | - | $973.50M(-56.3%) | $7.93B(-1.8%) |
| Dec 2021 | $8.08B(+129.9%) | $2.23B(+36.6%) | $8.08B(+15.4%) |
| Sep 2021 | - | $1.63B(-47.3%) | $7.00B(+12.7%) |
| Jun 2021 | - | $3.10B(+177.9%) | $6.21B(+55.0%) |
| Mar 2021 | - | $1.12B(-3.0%) | $4.00B(+14.0%) |
| Dec 2020 | $3.51B(+66.0%) | $1.15B(+36.5%) | $3.51B(+11.3%) |
| Sep 2020 | - | $842.10M(-6.2%) | $3.16B(+5.8%) |
| Jun 2020 | - | $897.30M(+43.7%) | $2.98B(+30.9%) |
| Mar 2020 | - | $624.60M(-21.1%) | $2.28B(+7.7%) |
| Dec 2019 | $2.12B(-13.4%) | $792.00M(+18.3%) | $2.12B(-1.3%) |
| Sep 2019 | - | $669.60M(+246.8%) | $2.14B(+3.6%) |
| Jun 2019 | - | $193.10M(-58.1%) | $2.07B(-14.8%) |
| Mar 2019 | - | $461.10M(-43.8%) | $2.43B(-0.7%) |
| Dec 2018 | $2.44B(+104.0%) | $820.40M(+38.0%) | $2.44B(+36.0%) |
| Sep 2018 | - | $594.65M(+7.8%) | $1.80B(+13.0%) |
| Jun 2018 | - | $551.41M(+15.4%) | $1.59B(+11.5%) |
| Mar 2018 | - | $477.98M(+175.5%) | $1.43B(+19.1%) |
| Dec 2017 | $1.20B(+33.8%) | $173.52M(-55.3%) | $1.20B(-6.2%) |
| Sep 2017 | - | $388.32M(+0.1%) | $1.28B(+10.7%) |
| Jun 2017 | - | $387.74M(+55.8%) | $1.15B(+19.9%) |
| Mar 2017 | - | $248.93M(-1.7%) | $963.07M(+7.5%) |
| Dec 2016 | $895.52M(+40.8%) | $253.12M(-4.4%) | $895.52M(+12.3%) |
| Sep 2016 | - | $264.80M(+35.0%) | $797.40M(+7.3%) |
| Jun 2016 | - | $196.22M(+8.2%) | $743.00M(+0.2%) |
| Mar 2016 | - | $181.38M(+17.0%) | $741.42M(+16.6%) |
| Dec 2015 | $636.06M(+82.7%) | $154.99M(-26.3%) | $636.06M(+7.6%) |
| Sep 2015 | - | $210.40M(+8.1%) | $591.24M(+28.4%) |
| Jun 2015 | - | $194.64M(+156.0%) | $460.56M(+28.4%) |
| Mar 2015 | - | $76.02M(-31.0%) | $358.65M(+3.0%) |
| Dec 2014 | $348.07M(-18.0%) | $110.18M(+38.2%) | $348.07M(+4.0%) |
| Sep 2014 | - | $79.72M(-14.0%) | $334.70M(-15.5%) |
| Jun 2014 | - | $92.73M(+41.7%) | $396.29M(+1.4%) |
| Mar 2014 | - | $65.44M(-32.4%) | $390.93M(-7.9%) |
| Dec 2013 | $424.36M(-43.4%) | $96.81M(-31.5%) | $424.36M(-46.8%) |
| Sep 2013 | - | $141.31M(+61.7%) | $797.96M(-5.9%) |
| Jun 2013 | - | $87.38M(-11.6%) | $848.13M(+1.3%) |
| Mar 2013 | - | $98.87M(-79.0%) | $837.49M(+11.6%) |
| Dec 2012 | $750.27M(+438.3%) | $470.41M(+145.7%) | $750.27M(+231.4%) |
| Sep 2012 | - | $191.47M(+149.5%) | $226.42M(+925.9%) |
| Jun 2012 | - | $76.74M(+558.7%) | -$27.41M(+83.6%) |
| Mar 2012 | - | $11.65M(+121.8%) | -$166.66M(+24.8%) |
| Dec 2011 | -$221.76M(-112.3%) | -$53.44M(+14.3%) | -$221.76M(-21.2%) |
| Sep 2011 | - | -$62.37M(+0.2%) | -$182.91M(-18.4%) |
| Jun 2011 | - | -$62.51M(-43.9%) | -$154.42M(-31.5%) |
| Mar 2011 | - | -$43.45M(-197.6%) | -$117.39M(-12.4%) |
| Dec 2010 | -$104.47M(-54.0%) | -$14.60M(+56.9%) | -$104.47M(+17.3%) |
| Sep 2010 | - | -$33.88M(-33.0%) | -$126.36M(-35.1%) |
| Jun 2010 | - | -$25.47M(+16.5%) | -$93.50M(-12.7%) |
| Mar 2010 | - | -$30.52M(+16.4%) | -$82.96M(-22.3%) |
| Dec 2009 | -$67.83M(+18.0%) | -$36.49M(-3495.0%) | -$67.83M(-7.9%) |
| Sep 2009 | - | -$1.01M(+93.2%) | -$62.86M(+24.2%) |
| Jun 2009 | - | -$14.94M(+2.9%) | -$82.96M(+4.1%) |
| Mar 2009 | - | -$15.39M(+51.2%) | -$86.48M(-4.6%) |
| Dec 2008 | -$82.71M(+21.7%) | -$31.52M(-49.3%) | -$82.71M(-28.7%) |
| Sep 2008 | - | -$21.11M(-14.4%) | -$64.26M(+18.6%) |
| Jun 2008 | - | -$18.46M(-58.9%) | -$78.99M(+9.5%) |
| Mar 2008 | - | -$11.62M(+11.1%) | -$87.30M(+17.3%) |
| Dec 2007 | -$105.60M | -$13.07M(+63.5%) | -$105.60M(+14.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | -$35.84M(-33.9%) | -$123.50M(-7.3%) |
| Jun 2007 | - | -$26.77M(+10.5%) | -$115.07M(-2.9%) |
| Mar 2007 | - | -$29.92M(+3.4%) | -$111.87M(-8.5%) |
| Dec 2006 | -$103.15M(-8.1%) | -$30.97M(-13.0%) | -$103.15M(-1.3%) |
| Sep 2006 | - | -$27.41M(-16.3%) | -$101.85M(+6.6%) |
| Jun 2006 | - | -$23.58M(-11.2%) | -$109.09M(+3.0%) |
| Mar 2006 | - | -$21.19M(+28.6%) | -$112.52M(-17.9%) |
| Dec 2005 | -$95.45M(-328.9%) | -$29.67M(+14.4%) | -$95.45M(-51.5%) |
| Sep 2005 | - | -$34.65M(-28.3%) | -$62.98M(-59.8%) |
| Jun 2005 | - | -$27.00M(-554.8%) | -$39.41M(-46.2%) |
| Mar 2005 | - | -$4.12M(-247.7%) | -$26.96M(-164.6%) |
| Dec 2004 | $41.70M(+138.8%) | $2.79M(+125.2%) | $41.70M(+113.5%) |
| Sep 2004 | - | -$11.08M(+23.9%) | $19.53M(+509.2%) |
| Jun 2004 | - | -$14.55M(-122.5%) | $3.21M(+129.2%) |
| Mar 2004 | - | $64.53M(+433.0%) | -$10.98M(+89.6%) |
| Dec 2003 | -$107.46M(+13.6%) | -$19.38M(+29.3%) | -$105.62M(+13.4%) |
| Sep 2003 | - | -$27.40M(+4.6%) | -$121.94M(+4.3%) |
| Jun 2003 | - | -$28.74M(+4.6%) | -$127.36M(+1.3%) |
| Mar 2003 | - | -$30.11M(+15.6%) | -$129.04M(-3.8%) |
| Dec 2002 | -$124.38M(-63.3%) | -$35.69M(-8.8%) | -$124.38M(-6.2%) |
| Sep 2002 | - | -$32.82M(-7.9%) | -$117.06M(-12.4%) |
| Jun 2002 | - | -$30.42M(-19.6%) | -$104.18M(-17.6%) |
| Mar 2002 | - | -$25.45M(+10.3%) | -$88.59M(-16.3%) |
| Dec 2001 | -$76.18M(-251.8%) | -$28.38M(-42.4%) | -$76.18M(-35.4%) |
| Sep 2001 | - | -$19.93M(-34.4%) | -$56.26M(-42.3%) |
| Jun 2001 | - | -$14.83M(-13.8%) | -$39.54M(-43.0%) |
| Mar 2001 | - | -$13.04M(-54.2%) | -$27.65M(-26.1%) |
| Dec 2000 | -$21.65M(+6.1%) | -$8.46M(-163.3%) | -$21.93M(-47.6%) |
| Sep 2000 | - | -$3.21M(-9.0%) | -$14.86M(+10.3%) |
| Jun 2000 | - | -$2.95M(+59.7%) | -$16.57M(+22.8%) |
| Mar 2000 | - | -$7.32M(-429.5%) | -$21.46M(+7.0%) |
| Dec 1999 | -$23.07M(-167.5%) | -$1.38M(+71.9%) | -$23.07M(+15.3%) |
| Sep 1999 | - | -$4.92M(+37.1%) | -$27.23M(-14.9%) |
| Jun 1999 | - | -$7.83M(+12.3%) | -$23.70M(-72.7%) |
| Mar 1999 | - | -$8.93M(-61.2%) | -$13.73M(-59.1%) |
| Dec 1998 | -$8.63M(+25.5%) | -$5.54M(-297.2%) | -$8.63M(-233.8%) |
| Sep 1998 | - | -$1.40M(-165.2%) | -$2.58M(+16.3%) |
| Jun 1998 | - | $2.14M(+155.9%) | -$3.09M(+67.6%) |
| Mar 1998 | - | -$3.83M(-865.8%) | -$9.53M(+17.9%) |
| Dec 1997 | -$11.58M(+64.3%) | $500.00K(+126.3%) | -$11.60M(+42.6%) |
| Sep 1997 | - | -$1.90M(+55.8%) | -$20.20M(+25.7%) |
| Jun 1997 | - | -$4.30M(+27.1%) | -$27.20M(+10.8%) |
| Mar 1997 | - | -$5.90M(+27.2%) | -$30.50M(+5.9%) |
| Dec 1996 | -$32.42M(-37.9%) | -$8.10M(+9.0%) | -$32.40M(-0.9%) |
| Sep 1996 | - | -$8.90M(-17.1%) | -$32.10M(-5.9%) |
| Jun 1996 | - | -$7.60M(+2.6%) | -$30.30M(-11.8%) |
| Mar 1996 | - | -$7.80M(0.0%) | -$27.10M(-15.3%) |
| Dec 1995 | -$23.51M(+23.3%) | -$7.80M(-9.9%) | -$23.50M(-9.3%) |
| Sep 1995 | - | -$7.10M(-61.4%) | -$21.50M(-16.8%) |
| Jun 1995 | - | -$4.40M(-4.8%) | -$18.40M(+24.0%) |
| Mar 1995 | - | -$4.20M(+27.6%) | -$24.20M(+21.2%) |
| Dec 1994 | -$30.65M(+23.1%) | -$5.80M(-45.0%) | -$30.70M(+15.7%) |
| Sep 1994 | - | -$4.00M(+60.8%) | -$36.40M(+13.3%) |
| Jun 1994 | - | -$10.20M(+4.7%) | -$42.00M(-1.9%) |
| Mar 1994 | - | -$10.70M(+7.0%) | -$41.20M(-3.5%) |
| Dec 1993 | -$39.88M(-108.7%) | -$11.50M(-19.8%) | -$39.80M(-14.7%) |
| Sep 1993 | - | -$9.60M(-2.1%) | -$34.70M(-12.3%) |
| Jun 1993 | - | -$9.40M(-1.1%) | -$30.90M(-22.6%) |
| Mar 1993 | - | -$9.30M(-45.3%) | -$25.20M(-31.3%) |
| Dec 1992 | -$19.11M(-327.8%) | -$6.40M(-10.3%) | -$19.20M(-28.9%) |
| Sep 1992 | - | -$5.80M(-56.8%) | -$14.90M(-49.0%) |
| Jun 1992 | - | -$3.70M(-12.1%) | -$10.00M(-51.5%) |
| Mar 1992 | - | -$3.30M(-57.1%) | -$6.60M(-50.0%) |
| Dec 1991 | -$4.47M(-35.4%) | -$2.10M(-133.3%) | -$4.40M(-37.5%) |
| Sep 1991 | - | -$900.00K(-200.0%) | -$3.20M(-3.2%) |
| Jun 1991 | - | -$300.00K(+72.7%) | -$3.10M(+13.9%) |
| Mar 1991 | - | -$1.10M(-22.2%) | -$3.60M(-9.1%) |
| Dec 1990 | -$3.30M | -$900.00K(-12.5%) | -$3.30M(-37.5%) |
| Sep 1990 | - | -$800.00K(0.0%) | -$2.40M(-50.0%) |
| Jun 1990 | - | -$800.00K(0.0%) | -$1.60M(-100.0%) |
| Mar 1990 | - | -$800.00K | -$800.00K |
FAQ
- What is Regeneron Pharmaceuticals, Inc. annual net profit?
- What is the all-time high annual net income for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. annual net income year-on-year change?
- What is Regeneron Pharmaceuticals, Inc. quarterly net profit?
- What is the all-time high quarterly net income for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. quarterly net income year-on-year change?
- What is Regeneron Pharmaceuticals, Inc. TTM net profit?
- What is the all-time high TTM net income for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. TTM net income year-on-year change?
What is Regeneron Pharmaceuticals, Inc. annual net profit?
The current annual net income of REGN is $4.41B
What is the all-time high annual net income for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high annual net profit is $8.08B
What is Regeneron Pharmaceuticals, Inc. annual net income year-on-year change?
Over the past year, REGN annual net profit has changed by +$459.00M (+11.61%)
What is Regeneron Pharmaceuticals, Inc. quarterly net profit?
The current quarterly net income of REGN is $1.39B
What is the all-time high quarterly net income for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high quarterly net profit is $3.10B
What is Regeneron Pharmaceuticals, Inc. quarterly net income year-on-year change?
Over the past year, REGN quarterly net profit has changed by -$40.70M (-2.84%)
What is Regeneron Pharmaceuticals, Inc. TTM net profit?
The current TTM net income of REGN is $4.46B
What is the all-time high TTM net income for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high TTM net profit is $8.08B
What is Regeneron Pharmaceuticals, Inc. TTM net income year-on-year change?
Over the past year, REGN TTM net profit has changed by +$136.90M (+3.17%)